RenovoRx RNXT
NASDAQ RNXT
$1.30 -0.02 (-1.14%)
As of: Aug 21, 2026 · 11:06 AM EDT

RenovoRx (RNXT) Operating Margin (QoQ) (2025 - 2026)

RenovoRx (RNXT) Operating Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.23 Bn 132.38 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.97 Bn 78.97 Bn 3.93 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn
4 Moderna 59.88 Bn 54.74 Bn 52.00 Mn
5 BeOne Medicines 42.20 Bn 37.11 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 28.69 Bn 10.30 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.16 Bn 26.33 Bn -
10 RenovoRx 61.72 Mn 61.72 Mn 766,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 24,774.00
Mar 31, 2026 86,367.00
Dec 31, 2025 -27,682.00
Sep 30, 2025 -56,841.00
Jun 30, 2025 94,408.00